Here, we also demonstrated that expression levels in peripheral blood mononuclear cells (PBMC) of surrogate markers of IFN bioactivity, ISG15 and ISG56, were reduced in COVID‐19 patients with circulating NAB against IFN‐I. The gene discussed is IFIT1; the disease is COVID-19.